In conclusion, we demonstrated that tumour-associated M2 macrophages but not M1 macrophages increase the growth and migration of hepatoma cells, confer hepatoma resistance to sorafenib treatment by secreting HGF. The gene discussed is HGF; the disease is hepatocellular carcinoma.